IAHRW International Journal of Social Sciences Review

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Corona Virus: An Emerging Threat to Mankind


Affiliations
1 Department of Public Health Dentistry, Manav Rachna Dental College, FDS, MRIIRS, Faridabad, Haryana, India
2 Manav Rachna Dental College, FDS, MRIIRS, Faridabad, Haryana, India
3 Oral Medicine and Radiology, Jazan, Saudi Arabia
     

   Subscribe/Renew Journal


COVID-19 pandemic has become an issue of international emergency. Newly available data from China, Europe, USA and India provides insight on this disease, its epidemiology and pathophysiology. These insights may guide in formulating strategies and interventions to contain and manage the outbreak. Pneumonia cases caused by novel beta corona virus first emerged in Wuhan, China in the end of 2019.This outbreak has brought the importance of analyzing the epidemiological data on the virus, its spread as well as on prediction of its spread, risk factors and outcomes. Based on the available data and published evidence, we systematically discuss the characteristics of COVID-19 for providing a reference for future studies and to find out ways for the prevention and control of the COVID-19 epidemic.

Keywords

COVID-19, SARS-CoV-2, 2019-nCoV, Pneumonia, Precautions.
User
Subscription Login to verify subscription
Notifications
Font Size

  • Al-Hazmi, A. (2016). Challenges presented by MERS corona virus, and SARS corona virus to global health. Saudi Journal of Biological Sciences, 23(4), 507-511.

  • Al-Tawfiq, J. A., Momattin, H., Dib, J., & Memish, Z. A. (2014). Ribavirin and interferon therapy in patients infected with the middle east respiratory syndrome coronavirus: an observational study. International Journal of Infectious Diseases, 20, 42-46.

  • Binnie, A., Tsang, J. L., & dos Santos, C. C. (2014). Biomarkers in acute respiratory distress syndrome. Current Opinion in Critical Care, 20, 47-55.

  • Chan, J.F., Chan, K.H., Kao, R.Y., To, K.K., Zheng, B.J., Li, C.P., Li, P.T., Dai, J., Mok, F.K., Chen, H., & Hayden, F.G. (2013). Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. Journal of Infection, 67(6), 606-616.

  • Chan, J.F.W., Yuan, S., Kok, K.H., To, K.K.T., Chu, H.C., & Yang, J., et al. (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. Dec 29, 2019 and Jan 4, 2020.

  • Chu, C.M., Cheng, V.C., Hung, I.F., Wong, M.M., Chan, K.H., Chan, K.S., Kao, R.Y., Poon, L.L., Wong, C.L., Guan, Y., & Peiris, J.S. (2004). Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings. Thorax, 59(3), 252-256.

  • de Wilde, A.H., Raj, V.S., Oudshoorn, D., Bestebroer, T.M., van Nieuwkoop, S., Limpens, R.W., Posthuma, C.C., van der Meer, Y., Barcena, M., Haagmans, B.L., & Snijder, E.J. (2013). MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin a or interferon-α treatment. The Journal of General Virology, 94(8), 1749.

  • De Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016). SARS and MERS: Recent insights into emerging coronaviruses. Nature Reviews Microbiology, 14(8), 523-534. doi:10.1038/nrmicro.2016.81

  • Dey, S. K., Rahman, M. M., Siddiqi, U. R., & Howlader, A. (2020). Analyzing the epidemiological outbreak of COVID-19: A visual exploratory data analysis (EDA) approach. Journal of Medical Virology, 92(6), 632-638. doi:10.1002/jmv.25743

  • Drosten, C., et al. (2013). Clinical features and virological analysis of a case of middle east respiratory syndrome coronavirus infection. Lancet Infectious Diseases, 13, 745-751.

  • Drosten, C., Günther, S., Preiser, W., Werf, S.V.D., Brodt, H.R., Becker, S., & Rabenau, H. (2003). Identification of a novel coronavirus in patients with severe acute respiratory syndrome. New England Journal of Medicine, 348, 1967-1976.

  • Du, L., Zhao, G., Yang, Y., Qiu, H., Wang, L., Kou, Z., Tao, X., Yu, H., Sun, S., Tseng, C.T., & Jiang, S. (2014). A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in middle east respiratory syndrome corona virus spike protein. Journal of Virology, 88(12), 7045-7053.

  • General Office of National Health Committee. Office of State Administration of Traditional Chinese Medicine (2020). Notice on the issuance of a program for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (Trial Version 3). Cited by 959 · Related articles.

  • Gonza´lez, J. M., Gomez-Puertas, P., Cavanagh, D., Gorbalenya, A. E., & Enjunes, L. (2003). A comparative sequence analysis to revise the current taxonomy of the family coronaviridae. Archives of Virology, 148, 2207-2235.

  • Gorbalenya, A. E., Enjuanes, L., Ziebuhr, J., & Snijder, E. J. (2006). Nidovirales: evolving the largest RNA virus genome. Virus Research, 117, 17-37.

  • Hart, B.J., Dyall, J., Postnikova, E., Zhou, H., Kindrachuk, J., Johnson, R.F., Olinger, Jr. G.G., Frieman, M.B., Holbrook, M.R., Jahrling, P.B., & Hensley, L. (2014).

  • Interferon-μ and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. The Journal of General Virology, 3, 571.

  • Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong,-Poi, H., Crackower, M. A., Fukamizu, A., Hui, C.C., Hein, L., Uhlig, S., Slutsky, A.S., Jiang, C., & Penninger, J.M. (2005). Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature, 436, 112-116.

  • International Severe Acute Respiratory & Emerging Infection Consortium (2013). Treatment of MERS-CoV: Decision support tool. International Severe Acute Respiratory & Emerging Infection Consortium, https:// isaric.tghn.org/site_media/media/articles/ Decision_Support_Document_v1_1_20130729.pdf (updated 29 July 2013).

  • Khalid, M., Al Rabiah, F., Khan, B., Al Mobeireek, A., Butt, T.S., & Al Mutairy, E. (2015). Case report Ribavirin and interferon-α2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: A preliminary report of two cases. Antiviral Therapy, 20, 87-91.

  • Lan, J., Yao, Y., Deng, Y., Chen, H., Lu, G., Wang, W., Bao, L., Deng, W., Wei, Q., Gao. G.F., & Qin, C. (2015). Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against Middle East respiratory syndrome coronavirus challenge. BioMedicine, 2(10), 1438-1446.

  • Li, L., Ren, M.J., Zhang, Y.Y., Li, W.Q., Zhao, H.Y., & Liang, L.C., & Lung, C.T. (2020). Image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS). YixueXinzhi, 30(1), 46.

  • Loutfy, M.R., Blatt, L.M., Siminovitch, K.A., Ward, S., Wolff, B., Lho, H., Pham, D.H., Deif, H., LaMere, E.A., Chang, M., & Kain, K.C. (2003). Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: A preliminary study. JAMA, 290(24), 3222-3228.

  • Masters, P. S. (2006). The molecular biology of coronaviruses. Advances in Virus Research, 66, 193-292.

  • Muthumani, K., Falzarano, D., Reuschel, E.L., Tingey, C., Flingai, S., Villarreal, D.O., Wise, M., Patel, A., Izmirly, A., Aljuaid, A., & Seliga, A.M. (2015). A synthetic consensus antispike protein DNA vaccine induces protective immunity against middle east respiratory syndrome coronavirus in nonhuman primates. Science Translational Medicine, 7(301), 301-132.

  • Omrani, A.S., Saad, M.M., Baig, K., Bahloul, A., Abdul-Matin, M., Alaidaroos, A.Y., Almakhlafi, G.A., Albarrak, M.M., Memish, Z.A., & Albarrak, A.M. (2014).

  • Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: A retrospective cohort study. The Lancet Infectious Diseases, 14(11), 1090-1095.

  • Peiris, J. S., et al. (2003). Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study. Lancet, 361, 1767 1772.

  • Peng, Z., Xing-Lou, Y., Xian-Guang, W., et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin, nature (doi: https://doi.org/10.1038/s41586-020-2012-7)

  • Roper, R. L., & Rehm, K. E. (2009). SARS vaccines: Where are we? Expert Review of Vaccines, 8, 887-898.

  • Roper, R. L., & Rehm, K. E. (2009). SARS vaccines: Where are we? Expert Review of Vaccines, 8, 887-898.

  • Shalhoub, S., et al. (2015). IFN-α2a or IFN-β1a in combination with ribavirin to treat middle east respiratory syndrome coronavirus pneumonia: A retrospective study. Journal of Antimicrobial Chemotherapy, 70, 2129-2132.

  • Snijder, E. J., Bredenbeek, P. J., Dobbe, J. C., Thiel, V., Ziebuhr, J., Poon, L. L. M., Guana, Y., Rozanov, M., Spaan, W. J. M., & Gorbalenya, A. E. (2003). Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineages. Journal of Molecular Biology, 331, 991-1004.

  • So, L.K., Lau, A.C., Yam, L.Y., Cheung, T.M., Poon, E., Yung, R.W., & Yuen, K.Y. (2003). Development of a standard treatment protocol for severe acute respiratory syndrome. The Lancet, 361(9369), 1615-1617.

  • Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., & Niu, P. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine. Cited by 8542 · Related articles. https://www.cdc.gov/coronavirus/2019-ncov/about/share-facts-h.pdf. (Accessed on 19.3.2020)

  • https://www.who.int/. (Accessed on 19.3.2020)


Abstract Views: 177

PDF Views: 0




  • Corona Virus: An Emerging Threat to Mankind

Abstract Views: 177  |  PDF Views: 0

Authors

Ankur Sharma
Department of Public Health Dentistry, Manav Rachna Dental College, FDS, MRIIRS, Faridabad, Haryana, India
Nisha Rani Yadav
Department of Public Health Dentistry, Manav Rachna Dental College, FDS, MRIIRS, Faridabad, Haryana, India
Meena Jain
Department of Public Health Dentistry, Manav Rachna Dental College, FDS, MRIIRS, Faridabad, Haryana, India
Arundeep Singh
Manav Rachna Dental College, FDS, MRIIRS, Faridabad, Haryana, India
D. D. S. V. Sindhuja
Manav Rachna Dental College, FDS, MRIIRS, Faridabad, Haryana, India
Indu Chaudhary
Manav Rachna Dental College, FDS, MRIIRS, Faridabad, Haryana, India
Aparna Aggarwal
Oral Medicine and Radiology, Jazan, Saudi Arabia

Abstract


COVID-19 pandemic has become an issue of international emergency. Newly available data from China, Europe, USA and India provides insight on this disease, its epidemiology and pathophysiology. These insights may guide in formulating strategies and interventions to contain and manage the outbreak. Pneumonia cases caused by novel beta corona virus first emerged in Wuhan, China in the end of 2019.This outbreak has brought the importance of analyzing the epidemiological data on the virus, its spread as well as on prediction of its spread, risk factors and outcomes. Based on the available data and published evidence, we systematically discuss the characteristics of COVID-19 for providing a reference for future studies and to find out ways for the prevention and control of the COVID-19 epidemic.

Keywords


COVID-19, SARS-CoV-2, 2019-nCoV, Pneumonia, Precautions.

References